Top Industry Leaders in the Vocal Cord Paralysis Market
Disclaimer: List of key companies in no particular orderLatest Vocal cord paralysis Companies Update
-
September 2022: The study is being led by the University of South Florida in Tampa, Florida, with participation from WeillCornell Medicine in New York City, ten other U.S. and Canadian institutions, and the French-American artificial intelligence (AI) biotech firm Owkin. The National Institutes of Health (NIH) has allocated $3.8 million for the first year of the initiative, with the possibility that the total award might reach $14 million if resources for the NIH are increased each year by Congress. Voice alterations have been linked to certain diseases with well-recognized unmet requirements, and the study team has selected five disease cohort groups for which this is the case, based on the current literature and continuing research. This research will collect information on a wide range of diseases, including those that affect the voice (such as laryngeal cancer, vocal fold paralysis, and benign laryngeal lesions).
- Expressable, a digital speech therapy firm, has secured a $4.5 million seed investment. The company uses telehealth services and asynchronous assistance to link patients with speech-language pathologists (SLP). The fledgling company's debut is geared squarely on helping the five million or so American youngsters who suffer from some form of speech impediment. What may begin as an occasional stutter may develop into a communication issue, so the startup hopes to intervene early to set children on a more positive course. Expresssable's in-house team of therapists use Zoom for Healthcare to conduct sessions in real time. From trouble with the public speaking to vocal cord paralysis, we'll find the right therapist for you.
List of Vocal cord paralysis Key companies in the market
- Stryker (US)
- Fujifilm Holdings Corporation (Japan
- Karl Storz GmbH & Co. KG (Germany)
- Teleflex Incorporated (US)
- Olympus Corporation (Japan)
- Medtronic (US)
- Cytophil, Inc. (US)
- Smiths Group plc (UK)
- LifeCell Corporation (US)
- Therapy Solutions Inc.